Principal Investigator
HAN Lianyi
Research Direction

bioinformatics and computer aided drug design; AI medical care; chronic disease management with medical AI; biocomputing and AIDD


Lianyi Han, recognized as Dr. Leo, is an internationally renowned expert in the field of bioinformatics, and will be a senior researcher at the Guangdong-Hong Kong-Macao Greater Bay Area Precision Medicine Research Institute (Guangzhou) from 2022, and a double-appointed senior researcher at the School of Life Sciences, Fudan University. He served as a former senior scientist of the US National Institutes of Health, Chief scientist of Tencent US Medical AI Laboratory, Tencent Principle Researcher, and the technical director of the first artificial intelligence chronic disease management platform for heart failure patients in China (a cooperation with Novartis and Tencent). In the field of bioinformatics and computer aided drug design, he has published 70+ SCI-indexed articles and filed 16 U.S. patents in the field of AI medical care. He is thoroughly experienced in the field of chronic disease management with medical AI. In his 20 years of experience on scientific research in biocomputing and AIDD, he uses AI/statistical learning/deep learning to solve bioinformatics, chemoinformatics, multimodal medical informatics, as well as research on real-world evidence and digital biomarkers. At present, the total number of citations on Dr. Leo's work reaches above 11,000 times, with an H-index of 35.